Ordering
Available Variants250 mg
CHA.16100-250mg
Price
€404.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
250 mg | CHA.16100-250mg | €404.00 |
powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C39H57O2P |
|---|---|
| CAS Number | 2197989-24-3 |
| Molecular Weight | 588.84 |
| UNSPSC Code | 12352128 |
| NACRES | NA.22 |
Safety Information Handling visibility
| hcodes | H413 |
|---|---|
| pcodes | P273 - P501 |
| Hazard Classifications | Aquatic Chronic 4 |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
AdCyBrettPhos, with a CAS number of 2197989-24-3, is a potent and selective inhibitor of adenylyl cyclase, an enzyme crucial for the production of cyclic adenosine monophosphate (cAMP) in cells. This compound has been utilized in various biochemical and pharmacological studies to elucidate the role of cAMP signaling pathways in cellular processes. By inhibiting adenylyl cyclase, AdCyBrettPhos effectively reduces intracellular cAMP levels, allowing researchers to investigate the downstream effects of cAMP depletion on cellular function and behavior. The specificity and efficacy of AdCyBrettPhos make it a valuable tool for probing the complex regulatory mechanisms involving cAMP, which is implicated in numerous physiological and pathological processes, including signal transduction, metabolism, and disease. As such, AdCyBrettPhos has contributed significantly to the understanding of cAMP-mediated signaling and its therapeutic potential.
